Atom Investors LP Cyma Bay Therapeutics, Inc. Transaction History

Atom Investors LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$12.63 - $24.47 $195,360 - $378,501	-15,468 Reduced 63.04%	9,070 $214,000
Q3 2023 Nov 14, 2023	BUY	$10.86 - $17.62 $266,482 - $432,359	24,538 New	24,538 $365,000
Q4 2020 Feb 16, 2021	SELL	$5.73 - $9.03 $123,063 - $193,937	-21,477 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$3.32 - $7.24 $71,303 - $155,493	21,477 New	21,477 $155,000

1.88M

Ticker CBAY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,677,904
Description
CymaBay Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and providing therapies to treat liver and other chronic diseases. Its lead product candidate is seladelpar (MBX-8025), a selective agonist of peroxisome proliferator activated receptor delta that is in phase III clinical study for the treatments of pri...

Get notified when there are updates to the investment portfolio of Atom Investors LP, based on Form 13F filings with the SEC.

Stay updated on Atom Investors LP with notifications on news.